AHNAK2 may promote the progression of PTC through cell adhesion-, cell junction-, and immune-related pathways, and methylation may serve as an upstream regulator to inhibit the expression and biological functions of AHNAK2. AHNAK2 also has extensive prognostic value in pan-cancer. This evidence concerns the gene AHNAK2 and cancer.